VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,453,000 | +84.6% | 100,000 | +75.1% | 0.04% | +65.4% |
Q1 2023 | $1,328,717 | -23.4% | 57,100 | -36.6% | 0.03% | +8.3% |
Q3 2022 | $1,734,000 | +127.0% | 90,000 | +200.0% | 0.02% | +118.2% |
Q2 2022 | $764,000 | -91.1% | 30,000 | -85.3% | 0.01% | -88.5% |
Q4 2021 | $8,552,000 | +486.6% | 204,300 | +509.9% | 0.10% | +464.7% |
Q3 2021 | $1,458,000 | -59.4% | 33,500 | -55.9% | 0.02% | -63.8% |
Q2 2021 | $3,594,000 | -52.0% | 76,000 | -47.9% | 0.05% | -70.8% |
Q1 2021 | $7,488,000 | – | 146,000 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |